Tuberculosis has been a scourge of humans over many millennia, but questions remain regarding its evolution and epidemiology. Fossil biomarkers, such as DNA and long-chain mycolic acids, can be detected in ancient skeletal and other materials. The phthiocerol dimycocerosate waxes are also robust biomarkers for tuberculosis and sensitive methods are available for the detection of their mycocerosic acid components. The presence of mycocerosic acids was investigated in 49 individuals from the 1837-1936 Coimbra Identified Skeletal Collection (Portugal), half with documentary data indicating tuberculosis as a cause of death. Samples were hydrolysed, acidic components converted to pentafluorobenzyl esters, the non-hydroxylated long-chain esters isolated, and this fraction separated into multimethyl-branched and other esters by normal phase high performance liquid chromatography. Negative ion chemical ionisation gas chromatography mass spectrometry was used to detect diagnostic C 29 , C 30 and C 32 mycocerosic acids. Mycocerosic acids were detected in archaeological material for the first time, illustrating that they are valuable biomarkers for the diagnosis of ancient tuberculosis. A 72% correlation with the Coimbra burial record supported TB as the major cause of death. In addition, 30% of the skeletons, positive for mycocerosates, showed the presence of related long-chain mycolipenic acids.
1. Introduction
Ancient tuberculosis
It was estimated that there were 8-9 million new cases of tuberculosis (TB) and 1.6 million deaths in 2005. 1 The continuing prevalence of this disease, caused by Mycobacterium tuberculosis, is partly due to the evolution of strains highly resistant to drug treatment and a higher incidence of human immunodeficiency virus (HIV) co-infection. 1 Cyclical changes in TB epidemiology could underlie these recent developments, 2,3 so it is important to study TB prevalence in ancient populations. By elucidating the origins and history of TB, an increase in the understanding of epidemiological patterns may develop. Historically, the study of gross morphological change in archaeologically derived skeletal material, particularly spinal destruction has been used for TB diagnosis in ancient populations. 4 A concern is the non-specificity of some of these gross morphological changes, for example in rib lesions 5, 6 and general bone changes. 6 Although TB is principally a disease of the respiratory tract, it can result in bone change in a low percentage of individuals. [7] [8] [9] Unfortunately, there is uncertainty surrounding the attribution of many bone changes to TB 10 ; other conditions, such as brucellosis and neoplasms, may cause similar alterations. 6 However, a dual biomarker study 11 has shown some support for macroscopic diagnostic methods, as have many aDNA studies of TB. [12] [13] [14] [15] In the last decade, ancient DNA (aDNA) analyses, using spoligotyping and sequencing techniques, have become established for characterisation of a wide range of biological samples, as exemplified by recent reports. [12] [13] [14] [15] For ancient TB diagnosis, primers that target the insertion sequence IS6110 are commonly used for identification. [16] [17] [18] [19] [20] Ancient DNA analysis also has the potential to discriminate between different species of the Mycobacterium tuberculosis complex, such as human and bovine. 21, 22 However, care must be taken when using the non-specific region of IS6110, as weak cross-reactivity has been found with Mycobacterium fortuitum. 23 Post-mortem oxidative and hydrolytic cleavage has also been shown to degrade DNA. 24 To validate results from ancient microbial DNA studies, recommendations for good laboratory practice have been suggested. 25, 26 Finally, due to the sensitivity of amplification, inferring whether a positive result is due merely to infection or the onset of clinical TB could be difficult to determine. 27 The use of chemically stable lipid biomarkers for TB diagnosis has been investigated as an alternative approach to ancient disease diagnosis. Mycobacteria produce a range of very unusual longchain lipids as components of the cell envelope, specific to the genus. 28 One such class, the mycolic acids, C 70 -C 90 , 2-alkyl, 3-hydroxy fatty acids, have been successfully detected in archaeological individuals, 11, 29, 30 using reversed and normal phase high performance liquid chromatography (HPLC) and fluorescence detection of mycolic acids tagged with 9-chloromethylanthracene.
The biomarker
In this study, another class of mycobacterial lipids, the mycocerosic acids, was investigated as biomarkers for TB diagnosis in archaeological individuals. Mycocerosic acids ( Figure 1 ) are long-chain multimethyl-branched-chain fatty acids 28 which are present in representatives of M. tuberculosis, Mycobacterium bovis, Mycobacterium gastri, Mycobacterium haemophilum, Mycobacterium kansasii, Mycobacterium leprae, Mycobacterium marinum and Mycobacterium ulcerans. [31] [32] [33] [34] [35] The mycocerosic acids of the mycobacteria are found mainly as phthiocerol dimycocerosate (PDIM) waxes or in phenolic glycolipids. [31] [32] [33] [34] [35] Their composition can be determined by simple gas chromatography (GC), but certain types of acids have essentially the same retention times. [36] [37] [38] For example, a C 29 mycocerosate with three methyl branches may overlap with a C 30 acid with four methyl branches. 31, 37, 38 In addition, M. tuberculosis produces a range of other multimethyl branched fatty acids 28, 33 and C 27 mycolipenate ( Figure 1) is one particularly characteristic acid that could easily be investigated along with the mycocerosates. In pioneering studies, 39 Larsson and colleagues showed that C 32 mycocerosates could be detected by GC-MS in five-day cultures of tuberculosis patient sputum samples. Individual mycocerosates have been determined successfully in clinical samples by selected ion monitoring (SIM) negative ion chemical ionisation gas chromatography mass spectrometry (NI-CI GC-MS). 36, 40 Using SIM GC-MS improves the analytical sensitivity and simplifies biomarker detection, as only the target analytes are monitored. Chemical analysis of archaeological material for these lipids using SIM GC-MS would thus provides a robust alternative technique to corroborate diagnoses achieved by other means, such as osteological changes, ancient DNA or mycolic acid biomarkers. It is important to be able to recognise the characteristic M. tuberculosis pattern of mycocerosates, typically trimethyl C 29 and tetramethyl C 30 and C 32. 31,32,37,38,40 In a limited systematic study, 31 Laboratory, Weybridge, UK; M. marinum ATCC 927, M. kansasii ATCC 12478 and M. bovis MNC 8 were cultivated as described previously. 31 Analytical grade chemicals (Sigma-Aldrich, Poole, Dorset, UK) and solvents (VWR International Ltd, Lutterworth, Leicestershire, UK) were used, unless stated otherwise.
Hydrolysis of biomass
Samples of bone (w1.0 g) and standard cells (50 mg) were hydrolysed overnight at 100 C in sealed 8.5 ml Pyrex tubes, with a PTFE-lined cap, using a solution of 30% w/v methanolic potassium hydroxide (2 ml) and toluene (1 ml). [36] [37] [38] After cooling to room temperature, the tubes were cooled to 0 C in an ice bath. The reaction mixtures were acidified to pH 1 by the addition of 10% aqueous HCl (1 ml) and dropwise addition of concentrated HCl. Long-chain compounds were extracted with diethyl ether (3 Â 1 ml). The combined organic extracts were evaporated to dryness under a stream of N 2 .
Preparation of standard pentafluorobenzyl esters
Total long-chain fractions from standard cells were transferred to 8.5 ml Pyrex tubes, with PTFE-lined caps. Pentafluorobenzyl (PFB) esters were prepared by tube rotator mixing, for 1 h, with phase-transfer catalyst solution (NaOH [0.8 g] and tetra-n-butylammonium hydrogen sulfate [3.39 g] in distilled water [100 ml]) (2 ml) and pentafluorobenzyl bromide [5 g] in dichloromethane [100 ml] (1 ml). 44 The upper aqueous layer was removed and the lower organic layer was washed successively with 10% aqueous HCl (1 ml) and distilled water (1 ml). The organic layer was evaporated to dryness under N 2 .
The dried residues were dissolved in minimal heptane. Each solution was applied to a 500 mg/4 ml Alltech 209250 normal phase cartridge (Alltech Associates, Carnforth, Lancashire, UK), prewashed with heptane, and the solvent was allowed to evaporate completely. An International Sorbent Technology (IST) Vacmaster FlashVac 20 vacuum tank, with a vacuum of À0.35 Torr, was used to fractionate the samples, according to the solvent elution regime . TLC analysis of the 8 fractions from normal phase cartridge separation of longchain compounds from M. tuberculosis PN, using the elution scheme detailed in Table 1 . MY, mycocerosic acid PFB ester; MA, mycolic acid PFB ester; P, phthiocerol; FA, other fatty acid PFB ester. TLC developed in petrol 60-80 C:ethyl acetate, 9:1 and components revealed by spraying with 10% ethanolic molybdophosphoric acid and charring. (Figure 2 ).
HPLC purification of mycocerosate PFB esters
Fractions 2 and 3 from the preliminary normal phase cartridge separation were analysed by normal phase HPLC. The system used was a Gilson 305 HPLC pump with an Applied Biosystems 759A UV detector (263 nm). The column was a Jones Chromatography (Hengoed, Cardiff, UK) Genesis silica 4 mm particle size, 250 mm by 4.6 mm i.d. The isocratic solvent system was 98:2 heptane:ethyl acetate (1 ml min
À1
) and the column was maintained at 30 C. This system allowed the clear separation of multimethyl-branched fatty acid PFB esters (retention factor k 0 ¼ 0.24) from other PFB fatty acid esters (retention factors k 0 ¼ 0.64-0.88). A standard sample of mycocerosate PFB ester had a retention factor k 0 of 0.22 in this system (see Figure 3 and Table 2 ).
Two co-markers were developed to facilitate collection of the correct fraction eluting from the column. To allow detection at a similar UV wavelength, a range of compounds, with pentafluorophenyl chromophores and suitable polarities, were investigated. It was found that decafluorobenzophenone (DFBP) (Figure 3 ) (Fluorochem, Glossop, Derbyshire, UK) (retention factor k 0 ¼ 0.29) eluted just after the multimethyl-branched fatty acid PFB esters (retention factor k 0 ¼ 0.22). To obtain a co-marker which eluted just before the mycocerosate peaks, a range of long-chain (C 6 , C 8 , C 12 , C 16 and C 18 ) esters of decafluorobenzhydrol were prepared by reaction with hexanoyl, octanoyl, dodecanoyl, hexadecanoyl and octadecanoyl chlorides, as follows. Decafluorobenzhydrol (50 mg, 1.4 Â 10 À4 mol) was placed in an 8.5 ml PTFE capped tube and dissolved in anhydrous dichloromethane (2 ml). The appropriate acid chloride (1.4 Â 10 À4 mol) was added along with 4-dimethylaminopyridine (17 mg, 1.4 Â 10 À4 mol). The solution was shaken thoroughly and left to stand overnight at room temperature. The solution was washed with 10% aqueous HCl (2 Â 1 ml), followed by distilled water (2 Â 1 ml), and dichloromethane evaporated under N 2 . The products were purified by preparative TLC in petrol 40 -60 C:ethyl acetate, 9:1, R f ¼ w0. Normal phase HPLC of the potential co-markers (Table 2) indicated that dodecanoic acid bis-pentafluorophenyl-methyl ester (DPFM) (Figure 3 ) was suitable as a co-marker (retention factor k 0 ¼ 0.12), eluting prior to the mycocerosic acid PFB esters. Optimum concentrations of the markers were chosen as the minimum amount that could be clearly seen at the maximum sensitivity of the UV detector. For the co-marker DPFM, this was determined to be 0.01 M in heptane; for co-marker DFPB this was determined to be 0.005 M in heptane. The solutions were mixed in a 1:1 ratio and 2.5 ml was added to each injection sample.
Extraction and purification of natural biomarkers
The non-hydroxylated fatty acid fractions, extracted from bone samples, were converted to PFB esters as detailed above. The crude esters were further fractionated using a normal phase Alltech 209250 cartridge, IST Vacmaster vacuum tank and elution system (Table 1), as outlined above. Fractions 2 and 3 from these separations were combined, evaporated to dryness, dissolved in HPLC grade heptane (20 ml) and 2.5 ml of the co-marker solution added, corresponding to ), with detection at 263 nm. Collection of the mycocerosate PFB fraction began when the peak of the co-marker DPFM appeared and continued until the appearance of the co-marker DFBP; the collected fraction was evaporated to dryness under N 2 . Between sample injections, the syringe was washed 40 times with HPLC grade heptane and the Rheodyne injection valve was washed 10 times in both the load and inject position. Blanks (heptane) were injected between each sample to ensure there was no cross-contamination.
NI-CI GC-MS conditions for analysis of PFB esters
SIR NI-CI GC-MS analyses of the purified PFB fractions were carried out at the Universities of Greenwich and Salford. In the initial study (Greenwich), a 30 m by 0.25 mm i.d. by 0.25 mm film (Scientific Glass Engineering, Milton Keynes, UK) BPX-5 (5% phenyl polysilphenyl-siloxane) capillary column (He carrier gas, column head pressure 10 psi; CI ammonia) was used in a VG 305 MS, using a 15 C/min temperature gradient from 175 to 300 C. The dried samples were dissolved in 20 ml octane, and 1 ml introduced through an autoinjector in splitless injection mode. Octane blanks were injected between samples.
In the quantitative study (Salford), a Varian 1200L Quad MS (CI methane, 3.6 Torr) was fitted with a Phenomenex (Macclesfield, Cheshire, UK) Zebron ZB-5 (5% phenyl, 95% dimethylpolysiloxane) 30 m by 0.25 mm i.d. by 0.25 mm film capillary column, using a head pressure of 8 psi and a gradient from 200 to 300 C at 20 C/min and holding at this temperature for 40 min. The ion source temperature was 260 C, the injector 250 C and the transfer line 300 C. The dried samples were dissolved in 20 ml octane, and 1 ml injected, using direct splitless injection. Octane blanks were analysed between samples, with a temperature range from 200 to 350 C at 20 C min À1 , over 27.5 min. Data were collected, using Varian MS Workstation software, version 6.2. At Greenwich, it was possible to monitor a wide range of ions, but the data system did not allow the collection of quantitative data; the ions studied were m/z 395 (C 26 mycocerosic acid), 409 (C 27 ), 437 (C 29 ), 451 (C 30 ), 479 (C 32 ), 493 (C 33 ) and 507 (C 34 ). Additionally, most extracts were monitored for m/z 407, corresponding to C 27 mycolipenate (Figure 1 ). In the light of the Greenwich results, it was decided to concentrate, at Salford, on obtaining quantitative data for the main characteristic m/z 437 (C 29 ), 451 (C 30 ) and 479 (C 32 ) mycocerosate ions, measuring peak areas. A C 31 standard, hentriacontanoic acid PFB ester, m/z 465, was used for relative retention and calibration studies at Salford.
Results and discussion

Extraction and purification of long-chain compounds
The PDIM waxes are extremely resistant to hydrolysis in aqueous media. 45 To obtain efficient release of the mycocerosic acids and phthiocerol components of PDIMs, the current low water alkaline hydrolysis procedure was developed. 37, 38 The suitability of this protocol was demonstrated by the efficient release of longchain compounds from the standard mycobacteria. The waterlimited conditions of the alkaline hydrolysis stage were also designed to promote racemization of the chiral centre at carbon-2 of the mycocerosates to produce diagnostic diastereoisomers due to the presence of an additional chiral methyl branch at carbon-4. As shown later, these diastereoisomers can be distinguished on gas chromatography of their PFB esters, visible as a second smaller peak immediately following the major peak. In contrast, mycolipenic acid derivatives produce a single peak as there is no chiral centre at carbon-2 ( Figure 4) . The released acidic components of hydrolysates were converted to PFB esters by an efficient phase-transfer catalysis procedure. 44 Long-chain components were separated on silica gel cartridges to produce fractions enriched in multimethyl-branched PFB esters, PFB esters of mycolates and underivatised phthiocerols, as shown in Figure 2 for standard extracts of M. tuberculosis. Fractions 2 and 3, contained the multimethyl-branched PFB esters (Figure 2 ), but they were accompanied by the usual C 12 -C 18 fatty acids, found in cellular plasma membrane lipids. To ensure effective GC-MS analyses, these fractions were further purified by normal phase HPLC.
The HPLC profile for the combined fractions 2 and 3 from standard M. tuberculosis is shown in Figure 5 . As shown by comparison with standard PFB mycocerosates, the multimethyl- branched components could be clearly separated from the other smaller PFB esters. Any PFB mycocerosate esters present in an archaeological sample would be below the UV detection limit, so suitable co-markers, DPFM and DFBP, were developed ( Figure 5 ), eluting immediately before and after the mycocerosates. This allowed successful collection and purification of the mycocerosate fractions from archaeological material. The co-markers were chosen to have essentially the same UV chromophore as the PFB esters. Conveniently, decafluorobenzophenone (DFBP) (Figure 3 ) was found to elute just after the PFB fraction containing the PFB mycocerosates. To obtain a suitable marker, eluting before the PFB mycocerosates, a range of long-chain esters of decafluorobenzhydrol were prepared (Table 2) ; it was found that dodecanoic acid bis-pentafluorophenyl-methyl (DPFM) ester eluted just before the PFB fraction containing the PFB mycocerosates ( Figure 5 ). Standard solutions were prepared for addition to the archaeological samples.
Diagnostic ion selection
Using the mycocerosic acid fraction from the standard M. tuberculosis, M. marinum, M. bovis and M. kansasii cells (data not shown), which correlated with published data, 38 No definitive ion signals were observed for the dimethyl-branched C 26 , pentamethyl-branched C 33 and tetramethyl-branched C 34 mycocerosates and these acids were excluded from this study. The C 27 mycocerosate ion (m/z 409) has value as a marker for M. marinum and M. bovis, being prevalent in both species 31, 38, 40 ; M. kansasii did not appear to be a contaminant of the site, as the profiles had major amounts of the C 32 mycocerosate. The most intense ions present in mycocerosic acid fraction from the standard M. tuberculosis PN cells ( Figure 6 ) were m/z 437 (C 29 ), m/z 451 (C 30 ) and m/z 479 (C 32 ), in agreement with previous studies 31, 36, 38, 40 ;
these ions were used for quantitative screening at Salford.
The sample set
The chosen individuals had been clinically examined between 1837 and 1936. Current TB diagnosis uses abnormal chest radiograph findings consistent with TB, fever, weight loss, a history of TB, a positive result on tuberculin skin test and haemoptysis. The initial indications are supported by laboratory confirmation, but even with all these modern tools, a diagnosis of TB is sometimes missed. 46 The sample set did not include individuals less than 15 years old at death, since diagnosis without laboratory support is much more problematic in children. 47 In modern cases, primary disease and its complications are more common in children than in adults, leading to differences in both clinical and radiographic manifestations 48 ; the sample set, therefore, was restricted to adults. The sample set was designed to include 50% of individuals recorded to have died from tuberculosis (Table 3) .
Initial study (Greenwich)
Summaries of the results obtained at the two centres are shown in Tables 3 and 4 . In the initial analyses, carried out at Greenwich, it was possible to monitor seven negative ions (m/z 395, 409, 437, 451, 479, 493, 507), corresponding to C 26, C 27 , C 29 , C 30, C 32, C 33 and C 34 mycocerosate carboxylates, as well as m/z 407, corresponding to the C 27 mycolipenate (Table 4) . A typical profile for a strongly positive bone sample (C8), determined in Greenwich, is shown in Figure 7 .
As expected, C 29 , C 30 and C 32 mycocerosates were present, but there was also a comparable C 27 mycocerosate. No evidence was seen for C 26, C 33 or C 34 mycocerosates in C8 or in any of the other bone extracts studied. The peak at 9:38 for m/z 395 ( Figure 7) is not C 26 mycocerosate; it is not a double peak and its retention time does not coincide with that (10:32) of C 27 mycocerosate, as shown in the profile (Figure 6 ) for the standard mycocerosates from M. tuberculosis. The profile for C8, did, however, show the presence of a signal attributable to C 27 mycolipenate and several other extracts were positive. The presence or absence of mycolipenates in the Coimbra bone extracts is summarized in Table 4 . The low intensity of the m/z 407 signal, in a minority of samples ( Table 4 ), indicated that the mycolipenate ion is a less effective biomarker for tuberculosis.
Quantitative study (Salford)
Using standard M. tuberculosis PN cells and hentriacontanoic acid (C 31 , m/z 465) as an internal marker, the relative retention of the C 29 , C 30 and C 32 ions on the Zebron ZB-5 column was 0.46, 0.47 and 0.63, respectively. To ascertain system performance, a six point calibration of hentriacontanoic acid, 18-3500 nM l À1 was undertaken. The linearity of the system was good, with a regression coefficient of 0.9995. The detection limit was calculated as 1.34 femtomoles, defined as twice the average peak to peak baseline, for a 1 mL injection. Due to the similarity of mycocerosate structure, a similar response was assumed for each component. A GC-MS total ion count (TIC) profile of the multimethyl-branched fraction purified from M. tuberculosis PN is shown in Figure 4 . As well as the expected mycocerosates, a substantial amount of C 27 mycolipenate is present as a single peak. At Salford, the analysis was limited to the trimethyl-branched C 29 (m/z 437) and tetramethyl-branched C 30 (m/z 451) and C 32 (m/z 479) mycocerosates in order to obtain good quantitative data. The C 32 mycocerosate (Table 4) (Table 4) . Typical profiles for the same strong positive sample (C8), as recorded at Greenwich (Figure 7) , and a weak positive (C26) are shown in Figure 8 .
Correlation of results
The results summarized in Table 4 provide a good correlation between the two separate Greenwich and Salford analyses. However, the enhanced sensitivity of the more focused study, in Salford, was able to detect two additional positive extracts (Table 4 , C27, 33). The data for the positive samples from the Coimbra extracts are correlated in Table 3 . It is notable that in the less quantitative Greenwich study the signals for the C 29 (m/z 437) mycocerosate were apparently enhanced (Table 3) . Of the 49 ribs analysed,16 (33%) were negative and others displayed various degrees of positivity. In most of the 33 positive cases ( (Table 4 ; C2, 6, 9-11, 22) where it predominated over the C 29 ester. It is of interest to correlate the mycocerosic acid detection to the burial record (Table 3) . Of the 33 mycocerosate positive samples, 22 of these correlated with a positive diagnosis for tuberculosis; only 2 skeletons diagnosed with pulmonary tuberculosis were negative for mycocerosates (Table 3 ; C32, 40). Eleven isolates (Table 3 ; C2, 6, 9, 16, 17, 19, 24, 26, 27, 29, 30) were positive for mycocerosates without an indication of tuberculosis; this indicates that specific lipid biomarkers can detect tuberculosis before bone lesions, or other physical manifestations, appear.
Preservation potential of the biomarker
The diagnosis of tuberculosis in archaeological skeletal samples can be more difficult than for living patients, as there is no living patient to assess signs and symptoms and often no associated specific pathological change. Another problem, aside from site contamination, is the diagenetic (post-mortem modification by a variety of routes) alteration of the biomarker. Although more resistant than other types of biomolecule, 49 lipids such as mycocerosic acids are potentially susceptible to diagenetic change. The main route of diagenesis for many lipids is hydrolysis of the ester bond followed by decarboxylation 50 ; generally, long-chain fatty acids (C 20 -C 34 ) are more resistant than shorter chain analogues. 51 Diagenetic change, resulting in mycocerosic acid decarboxylation would make the resulting alkane undetectable, as it could not be derivatised.
There is also a hierarchy for stability with unsaturated fatty acids being more reactive than branched fatty acids, which are more reactive than straight-chain fatty acids. 52 It is unlikely, however, that diagenetic reactions would result in an enrichment with longer chain mycocerosic acids, since no simple relationship exists between the rate of diagenetic loss and chain length. 53, 54 High concentrations of C 32 mycocerosate surviving in the bone are therefore strongly indicative of members of the M. tuberculosis complex, allowing no confusion with any other mycobacteria. The form in which these lipids exist in the bone may have an effect on survival. Mycocerosic acids are diesterified to the phthiocerols, with the resultant phthiocerol dimycocerosate being over 100 carbons in size and highly resistant to hydrolysis. 45 Additionally, mycocerosic acids are present as the lipid moiety in phenolic glycolipids (PGLs) found in M. bovis and unusual ''Canetti'' variants of M. tuberculosis. 32, 33, 35 The hydrophilic sugar moieties of PGLs might be relatively more susceptible to diagenetic loss. The detection of C 27 mycolipenates in a significant number of samples (Table 4) is interesting. Mycolipenates occur as diacyl trehaloses 33 and these relatively polar glycolipids would be expected to degrade more rapidly. However, diacyl trehaloses are less regularly encountered than phthiocerol dimycocerosates, 33 so it is unclear if the reduced detection (Table 4 ) is due to selective diagenesis, perhaps due to the presence of a double bond, or limited synthesis in the original infecting agent. Preservation of fatty acids would be further enhanced from their inclusion into microbially inaccessible matrices. 55 Fatty acids adsorb to the surface pores of natural geosorbents 56 and are protected from degradation. 55 Fatty acids not protected by mineral pores have an average turnover time of between 21 and 49 years. 57 Bone contains such small pores 54, 58 and it is hypothesized that these afford protection for the mycobacterial lipids. Bones were graded as good, moderate and poor (Table 3) , but the degree of bone degradation did not appear to have an effect on mycocerosate recovery. 
Conclusions
Mycocerosic acid biomarkers, for M. tuberculosis, have been identified in archaeological samples for the first time, using the Coimbra Identified Skeletal Collection 41, 42 as a test case. The analytical procedure is designed to be a component of an integrated method designed to maximise the amount of information from a range of characteristic lipid biomarkers. When considering destructive analysis of irreplaceable material, such as archaeological samples, it is of paramount importance to preserve all extracted material in a stable form. Such extracts would then be available for future analysis, using increasingly sophisticated and sensitive procedures.
In the present procedure, efficient alkaline hydrolysis is followed by conversion of acidic components to stable PFB esters. Reproducible normal phase cartridge protocols then separate potential long-chain biomarkers into three main fractions for separate analysis. The first eluting non-hydroxylated PFB esters can be analysed by negative ion chemical ionisation gas chromatography mass spectrometry to record characteristic profiles of mycocerosic acids and any other potential biomarker acids, such as the mycolipenic acids detected in some of the present samples. The next fraction contains the hydroxylated mycolic acid PFB esters and a new procedure has been devised to analyse these by fluorescence HPLC of 1-pyrenebutyric acid ester derivatives. 59 The final fraction from the cartridge separation contains the phthiocerol family which could be derivatised with PBA for fluorescence HPLC or a variety of other sensitive procedures. Analysis of mycocerosic acid biomarkers, introduced in this study, adds another weapon in the search for information regarding ancient mycobacterial disease in archaeological materials. Lipid biomarkers, such as mycocerosic and mycolic acids, are particularly robust and are ideal in complementing detection of ancient DNA. 11, 29, 59 In certain cases, mycolic acid biomarkers have been detected in archaeological samples which have been found negative for M. tuberculosis DNA.
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